Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging

BACKGROUND: Oral deferiprone was suggested to be more effective than subcutaneous desferrioxamine for removing heart iron. Oral once-daily chelator deferasirox has recently been made commercially available but its long-term efficacy on cardiac iron and function has not yet been established. Our stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pepe, Alessia, Meloni, Antonella, Capra, Marcello, Cianciulli, Paolo, Prossomariti, Luciano, Malaventura, Cristina, Putti, Maria Caterina, Lippi, Alma, Romeo, Maria Antonietta, Bisconte, Maria Grazia, Filosa, Aldo, Caruso, Vincenzo, Quarta, Antonella, Pitrolo, Lorella, Missere, Massimiliano, Midiri, Massimo, Rossi, Giuseppe, Positano, Vincenzo, Lombardi, Massimo, Maggio, Aurelio
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2011
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3012763/
https://ncbi.nlm.nih.gov/pubmed/20884710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.019042
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky